Tech Company Financing Transactions

Inflazome Funding Round

Inflazome, operating out of Dublin, secured $17 million in investment from Fountain Healthcare Partners, Novartis Venture Fund and private investors.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

32 Kildare St.
Dublin, 2
Ireland

Phone

+353 1 687 5002

Website

www.inflazome.com

Email Address

[email protected]

Overview

We are dedicated to improving lives by delivering new medicines that stop inflammation. Our founders are globally acknowledged scientific leaders whose vision is to transition their work from the lab to life.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Matthew Cooper

        

Chief Scientific Officer

Luke O'Neill

        

VP - Bus. Development

Jeremy Skillington

        

VP - Finance

Conor Dalton

        

VP - R & D

Angus MacLeod

        

VP - Regulatory Affairs

Joanna Tufnell

        

Browse more venture capital transactions:

Prev: 9/13/2016: AcuFocus venture capital transaction
Next: 9/13/2016: Avitide venture capital transaction

Share this article

About Our Venture Capital Transactions Database

We do our best to report on every notable VC transaction. VC transactions reported here are derived from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary